Ebola cases top 11,000 at six-month mark, challenges remain: Africa CDC

IANS | November 13, 2026 8:55 PM

Addis Ababa, Nov 13 (IANS) The number of confirmed Ebola cases has surpassed 11,000, with the death toll still rising, as Africa marked six months since the beginning of the Bundibugyo Ebola outbreak, the Africa Centres for Disease Control and Prevention (Africa CDC) has said.

Cost of distance: UP's Gorakhpur brings childhood cancer care closer to home

IANS | November 13, 2026 8:41 PM

Gorakhpur, Nov 13 (IANS) Uttar Pradesh Chief Minister Yogi Adityanath's Gorakhpur constituency is emerging as a model for decentralised childhood cancer care with the state government, along with other stakeholders, strengthening regional treatment hubs, shared-care networks and financial protection.

Manipal Health's Q2 net profit drops 13 pc to Rs 270 crore

IANS | November 13, 2026 7:15 PM

Mumbai, Nov 13 (IANS) Manipal Health Enterprises Limited on Friday reported a 13.2 per cent year-on-year (YoY) decline in net profit for the second quarter of FY27, with profit falling to Rs 270 crore from Rs 311 crore a year earlier (Q2 FY26).

21st Delhi Critical Care symposium seeks to educate young medics about mechanical ventilation, bronchoscopy

IANS | November 13, 2026 5:44 PM

Noida, Nov 13 (IANS) Doctors attending the 21st Delhi Critical Care Symposium (DCCS 2026), being held from November 13-15, under the theme "Critical Care Redefined: Evidence, Expertise, Excellence", said the lecture series and workshops aim to teach 'mechanical ventilation and bronchoscopy' to young medical professionals serving in Intensive Care Units (ICU).

Centre directs strict vigil to enforce lower prices for 137 anti-cancer drugs

IANS | November 13, 2026 1:41 PM

New Delhi, Nov 13 (IANS) The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has directed strict monitoring of the implementation of Trade Margin Rationalisation (TMR) on 137 non-scheduled anti-cancer drugs, for which the reduced prices came into effect from November 9, an official statement said on Friday.

Alkem Labs' Q2 profit falls 12 pc to Rs 675 crore

IANS | November 12, 2026 3:46 PM

Mumbai, Nov 12 (IANS) Pharmaceutical major Alkem Laboratories on Thursday reported an 11.8 per cent year-on-year (YoY) decline in consolidated net profit to Rs 675 crore for the quarter ended September 2026 (Q2 FY27), even as strong growth in domestic and international businesses helped drive double-digit revenue expansion.